Alkermes(US:ALKS) Prnewswireยท2025-07-15 20:00Company Overview - Alkermes plc is a global biopharmaceutical company focused on developing innovative medicines in neuroscience [3] - The company has a portfolio of proprietary commercial products targeting alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder [3] - Alkermes is headquartered in Ireland, with additional offices in Massachusetts and a manufacturing facility in Ohio [3] Upcoming Financial Event - Alkermes will host a conference call and webcast presentation on July 29, 2025, at 8:00 a.m. ET to discuss its second quarter financial results [1] - The conference call can be accessed by U.S. callers at +1 877 407 2988 and international callers at +1 201 389 0923 [2] - A replay of the webcast will be available approximately two hours after the event on Alkermes' website [2]